FAscinant quand même! ALain _____
From: [EMAIL PROTECTED] [mailto:[EMAIL PROTECTED] On Behalf Of "Équipe éditoriale de amc.ca" Sent: 2 septembre 2008 05:21 To: [EMAIL PROTECTED] Subject: InfoPOEM: CPAP and NIPPV no better than O2 in acute pulmonary edema (3CPO) Pour assurer la livraison de ce courriel dans votre boîte de réception, veuillez ajouter [EMAIL PROTECTED] <mailto:[EMAIL PROTECTED]> à votre carnet de contacts. <http://www.cma.ca/multimedia/CMA/NewsLetters/InfoPOEMs/French/Header.jpg> CPAP and NIPPV no better than O2 in acute pulmonary edema (3CPO) Clinical question Does noninvasive ventilation improve outcomes in patients with acute cardiogenic pulmonary edema? Bottom line In patients with acute cardiogenic pulmonary edema, continuous positive airway pressure (CPAP) and noninvasive positive pressure support (NIPPV) do not reduce mortality or the risk of requiring intubation more than standard oxygen therapy. They may provide a small benefit in terms of greater relief of dyspnea. (LOE = <http://mailer.cma.ca/t/3129055/234493/102001/0/> 1b) Reference Gray A, Goodacre S, Newby DE, et al, for <http://mailer.cma.ca/t/3129055/234493/822001/0/> the 3CPO Trialists. Noninvasive ventilation in acute cardiogenic pulmonary edema. N Engl J Med 2008;359(2):142-151. Study design Randomized controlled trial (nonblinded) Funding Government Allocation Concealed Setting Inpatient (any location) <http://www.cma.ca/multimedia/CMA/NewsLetters/InfoPOEMs/Bullet.gif> Obtenez <http://mailer.cma.ca/t/3129055/234493/822251/0/> des crédits Mainpro <http://www.cma.ca/multimedia/CMA/NewsLetters/InfoPOEMs/Bullet.gif> Discutez <http://mailer.cma.ca/t/3129055/234493/822226/0/> de cet InfoPOEM <http://www.cma.ca/multimedia/CMA/NewsLetters/InfoPOEMs/Bullet.gif> Archives <http://mailer.cma.ca/t/3129055/234493/145011/0/> <http://www.cma.ca/multimedia/CMA/NewsLetters/InfoPOEMs/Bullet.gif> Bilan <http://mailer.cma.ca/t/3129055/234493/177011/0/> des crédits <http://www.cma.ca/multimedia/CMA/NewsLetters/InfoPOEMs/Bullet.gif> Plus <http://mailer.cma.ca/t/3129055/234493/3021/0/> de FMC / DPC <http://mailer.cma.ca/t/3129055/234493/45002/0/> Publicité <http://www.cma.ca/multimedia/CMA/NewsLetters/InfoPOEMs/Envelop.gif> Envoyez-nous vos <mailto:[EMAIL PROTECTED]> commentaires Synopsis The optimal approach to noninvasive ventilation for patients with acute cardiogenic pulmonary edema remains unclear, with only a few small randomized controlled trials. CPAP provides the same level of positive airway pressure throughout the respiratory cycle, while NIPPV increases pressure more during inspiration than during expiration. There are theoretical reasons to think that NIPPV may be better, but it has also been associated with a greater risk of acute myocardial infarction. In this study, 1069 adults with acute cardiogenic pulmonary edema at 26 United Kingdom emergency departments were randomized to receive oxygen therapy, CPAP, or NIPPV. All patients had pulmonary edema on chest x-ray, a pH of less than 7.35, and a respiratory rate greater than 20 breaths per minute. Their mean age was 78 years and 57% were women. All patients received the assigned treatment for at least 2 hours, with the duration of further treatment determined by the treating physician. Groups were balanced at the start of the study and analysis was by intention to treat. Overall adherence to the assigned treatment was good, although patients initially assigned to oxygen were more likely to change therapy because of respiratory distress (8.4% vs 1.4% for CPAP and 3.4% for NIPPV; P < .001), while those assigned to NIPPV were more likely to change therapy because of patient discomfort (8.4% vs 5.2% for CPAP and 0.3% for oxygen; P < .001). After 7 days, there was no significant difference between groups regarding rates of mortality or need for intubation, or regarding mortality at 30 days. Patients receiving CPAP or NIPPV had a greater improvement on a 10-point dyspnea score than those receiving oxygen alone (4.6 vs 3.9 points), but this difference is of questionable clinical significance. There were also greater improvements in arterial pCO2 and pH, but again the clinical significance is uncertain. Discutez de <http://mailer.cma.ca/t/3129055/234493/822226/0/> cet InfoPOEM Archives InfoPOEMs <http://mailer.cma.ca/t/3129055/234493/145011/0/> (contenu anglais) | CLIPs <http://mailer.cma.ca/t/3129055/234493/322001/0/> (contenu anglais) | Critique <http://mailer.cma.ca/t/3129055/234493/177003/0/> et pratique Ressources cliniques Accueil <http://mailer.cma.ca/t/3129055/234493/94016/0/> | Manuels <http://mailer.cma.ca/t/3129055/234493/177004/0/> | Revues <http://mailer.cma.ca/t/3129055/234493/177005/0/> | Information <http://mailer.cma.ca/t/3129055/234493/145012/0/> médicaments | Tests <http://mailer.cma.ca/t/3129055/234493/128015/0/> de laboratoire | InfoPOEMs <http://mailer.cma.ca/t/3129055/234493/145011/0/> | Guide <http://mailer.cma.ca/t/3129055/234493/177006/0/> de pratique clinique | Documents <http://mailer.cma.ca/t/3129055/234493/177007/0/> d'information pour les patients | Bibliothécaire <http://mailer.cma.ca/t/3129055/234493/147004/0/> de l'AMC Raccourcis MD <http://mailer.cma.ca/t/3129055/234493/145015/0/> Consult | STAT!Ref <http://mailer.cma.ca/t/3129055/234493/148015/0/> | [EMAIL PROTECTED] <http://mailer.cma.ca/t/3129055/234493/177008/0/> | OVID <http://mailer.cma.ca/t/3129055/234493/145016/0/> Medline | Revues <http://mailer.cma.ca/t/3129055/234493/145014/0/> EBSCO | JAMC <http://mailer.cma.ca/t/3129055/234493/177009/0/> | Essential <http://mailer.cma.ca/t/3129055/234493/138018/0/> Evidence Plus | MedCalc <http://mailer.cma.ca/t/3129055/234493/177010/0/> 3000 FMC / DPC Voir les <http://mailer.cma.ca/t/3129055/234493/3021/0/> cours en ligne | Bilan <http://mailer.cma.ca/t/3129055/234493/177011/0/> des crédits Gestion de la pratique Accueil <http://mailer.cma.ca/t/3129055/234493/77020/0/> | Créez un <http://mailer.cma.ca/t/3129055/234493/140/0/> site Web de pratique | Clinique <http://mailer.cma.ca/t/3129055/234493/234014/0/> informatisée | Bureau <http://mailer.cma.ca/t/3129055/234493/234015/0/> | Dotation <http://mailer.cma.ca/t/3129055/234493/234016/0/> en personnel | Finances <http://mailer.cma.ca/t/3129055/234493/234017/0/> | Juridique <http://mailer.cma.ca/t/3129055/234493/234018/0/> et vie privée POEMs veut dire "Patient-Oriented Evidence that Matters". Désirez-vous changer le format de vos courriels d'InfoPOEMs quotidiens ou votre adresse courriel de la liste d'InfoPOEMs quotidiens? Gérez vos options <http://mailer.cma.ca/t/3129055/234493/3026/0/> d'InfoPOEMs quotidiens à partir du site Web amc.ca. Cliquez ici pour vous désabonner <http://mailer.cma.ca/u?id=234493.2ee32010d4b1d8089bbf2b767ebd5713&o=3129055 &u=http://www.cma.ca/index.cfm/ci_id/324/la_id/2.htm&w=F&a=T&c=F&l=poem> . Copyright © 1995-2008 InfoPOEM, Inc. www.infopoems.com <http://mailer.cma.ca/t/3129055/234493/3013/0/> . Tous droits réservés. Copyright © 2008 Association Médicale Canadienne, Tous droits réservés. <http://mailer.cma.ca/do/3129055/234493/1.gif>
